Showing 5,401 - 5,420 results of 28,667 for search '(( 5 ((ng decrease) OR (nn decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.63s Refine Results
  1. 5401
  2. 5402
  3. 5403

    The C-terminal tyrosine of α-tubulin is required for centration/rotation of the nucleus-centrosome complex but not for MT tip tracking of dynactin. by Daniel J. Barbosa (4288462)

    Published 2017
    “…<b>(I)</b> <i>(left)</i> Cortical confocal section of a control and <i>tba-1/2(YA/YA)</i> one-cell embryo in metaphase expressing GFP::p50<sup>DNC-2</sup>. …”
  4. 5404
  5. 5405

    Bmi1 Essentially Mediates Podocalyxin-Enhanced Cisplatin Chemoresistance in Oral Tongue Squamous Cell Carcinoma by Yueying Zhou (450705)

    Published 2015
    “…On the other hand, knockdown of PODXL significantly decreased the Bmi1 expression level and cisplatin IC50 and increased cisplatin-induced cell apoptosis, which was completely reversed by overexpression of Bmi1. …”
  6. 5406
  7. 5407

    Monodispersed Sirolimus-Loaded PLGA Microspheres with a Controlled Degree of Drug–Polymer Phase Separation for Drug-Coated Implantable Medical Devices and Subcutaneous Injection by Zilin Zhang (4370773)

    Published 2022
    “…By increasing the drug loading from 33 to 50 wt %, the particle morphology evolved from homogeneous microspheres, in which the drug and polymer were perfectly mixed, to patchy particles, with amorphous drug patches embedded within a polymer matrix to anisotropic patchy Janus particles. …”
  8. 5408

    Monodispersed Sirolimus-Loaded PLGA Microspheres with a Controlled Degree of Drug–Polymer Phase Separation for Drug-Coated Implantable Medical Devices and Subcutaneous Injection by Zilin Zhang (4370773)

    Published 2022
    “…By increasing the drug loading from 33 to 50 wt %, the particle morphology evolved from homogeneous microspheres, in which the drug and polymer were perfectly mixed, to patchy particles, with amorphous drug patches embedded within a polymer matrix to anisotropic patchy Janus particles. …”
  9. 5409
  10. 5410
  11. 5411
  12. 5412
  13. 5413
  14. 5414
  15. 5415
  16. 5416
  17. 5417

    Suitability of Porcine Chondrocyte Micromass Culture To Model Osteoarthritis in Vitro by Niels Schlichting (1783198)

    Published 2014
    “…Expression of genes related to cartilage ECM formation (<i>COL2A1</i>, <i>COL9A1</i>, <i>COMP</i>, <i>aggrecan</i>) as well as hypertrophic bone formation (<i>COL1A1</i>, <i>COL10A1</i>) was predominantly found decreased. …”
  18. 5418

    Suitability of Porcine Chondrocyte Micromass Culture To Model Osteoarthritis in Vitro by Niels Schlichting (1783198)

    Published 2014
    “…Expression of genes related to cartilage ECM formation (<i>COL2A1</i>, <i>COL9A1</i>, <i>COMP</i>, <i>aggrecan</i>) as well as hypertrophic bone formation (<i>COL1A1</i>, <i>COL10A1</i>) was predominantly found decreased. …”
  19. 5419

    Suitability of Porcine Chondrocyte Micromass Culture To Model Osteoarthritis in Vitro by Niels Schlichting (1783198)

    Published 2014
    “…Expression of genes related to cartilage ECM formation (<i>COL2A1</i>, <i>COL9A1</i>, <i>COMP</i>, <i>aggrecan</i>) as well as hypertrophic bone formation (<i>COL1A1</i>, <i>COL10A1</i>) was predominantly found decreased. …”
  20. 5420

    Suitability of Porcine Chondrocyte Micromass Culture To Model Osteoarthritis in Vitro by Niels Schlichting (1783198)

    Published 2014
    “…Expression of genes related to cartilage ECM formation (<i>COL2A1</i>, <i>COL9A1</i>, <i>COMP</i>, <i>aggrecan</i>) as well as hypertrophic bone formation (<i>COL1A1</i>, <i>COL10A1</i>) was predominantly found decreased. …”